Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Topical Imiquimod and Weekly Abraxane for the Treatment of Breast Cancer Cutaneous Metastases

NCT00821964 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT00821964
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00821964 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Topical Imiquimod and Weekly Abraxane for the Treatment of Breast Cancer Cutaneous Metastases
Lead sponsor
University of Washington
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2008
Completion date
November 29, 2012
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

male breast cancer, recurrent breast cancer, skin metastases, stage iv breast cancer